Quinolizidinone M1 receptor positive allosteric modulators

Details for Australian Patent Application No. 2008311971 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Chang, Ronald K.; Kuduk, Scott D.

Agent Spruson & Ferguson

Pub. Number AU-A-2008311971

PCT Pub. Number WO2009/051715

Priority 60/999,424 18.10.07 US

Filing date 15 October 2008

Wipo publication date 23 April 2009

International Classifications

C07D 455/02 (2006.01) Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine

A61K 31/4375 (2006.01)

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

22 April 2010 PCT application entered the National Phase

  PCT publication WO2009/051715 Priority application(s): WO2009/051715

8 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008311973-Human Factor IX variants with an extended half life

2008311962-Peptide compounds for treating obesity and insulin resistance